Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Other Accumulated Expenses (2017 - 2023)

Q32 Bio (QTTB) has 7 years of Other Accumulated Expenses data on record, last reported at $8.2 million in Q3 2023.

  • For Q3 2023, Other Accumulated Expenses rose 1523.37% year-over-year to $8.2 million; the TTM value through Sep 2023 reached $8.2 million, up 1523.37%, while the annual FY2022 figure was $2.3 million, 6016.22% up from the prior year.
  • Other Accumulated Expenses reached $8.2 million in Q3 2023 per QTTB's latest filing, down from $12.6 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $12.6 million in Q2 2023 and bottomed at $37000.0 in Q4 2021.
  • Average Other Accumulated Expenses over 5 years is $3.2 million, with a median of $2.3 million recorded in 2022.
  • Peak YoY movement for Other Accumulated Expenses: crashed 98.45% in 2021, then skyrocketed 6016.22% in 2022.
  • A 5-year view of Other Accumulated Expenses shows it stood at $256000.0 in 2019, then surged by 834.77% to $2.4 million in 2020, then plummeted by 98.45% to $37000.0 in 2021, then surged by 6016.22% to $2.3 million in 2022, then surged by 262.26% to $8.2 million in 2023.
  • Per Business Quant database, its latest 3 readings for Other Accumulated Expenses were $8.2 million in Q3 2023, $12.6 million in Q2 2023, and $9.2 million in Q1 2023.